These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15028118)

  • 21. Human pituitary glutaminyl cyclase: expression in insect cells and dye affinity purification.
    Booth RE; Misquitta SA; Bateman RC
    Protein Expr Purif; 2003 Nov; 32(1):141-6. PubMed ID: 14680951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterologous expression and characterization of human glutaminyl cyclase: evidence for a disulfide bond with importance for catalytic activity.
    Schilling S; Hoffmann T; Rosche F; Manhart S; Wasternack C; Demuth HU
    Biochemistry; 2002 Sep; 41(35):10849-57. PubMed ID: 12196024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis.
    Huang KF; Wang YR; Chang EC; Chou TL; Wang AH
    Biochem J; 2008 Apr; 411(1):181-90. PubMed ID: 18072935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta.
    Cynis H; Scheel E; Saido TC; Schilling S; Demuth HU
    Biochemistry; 2008 Jul; 47(28):7405-13. PubMed ID: 18570439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in zinc ligation promote remodeling of the active site in the zinc hydrolase superfamily.
    Wouters MA; Husain A
    J Mol Biol; 2001 Dec; 314(5):1191-207. PubMed ID: 11743734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-Pyruvoyl tetrahydropterin synthase, an enzyme with a novel type of active site involving both zinc binding and an intersubunit catalytic triad motif; site-directed mutagenesis of the proposed active center, characterization of the metal binding site and modelling of substrate binding.
    Bürgisser DM; Thöny B; Redweik U; Hess D; Heizmann CW; Huber R; Nar H
    J Mol Biol; 1995 Oct; 253(2):358-69. PubMed ID: 7563095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators.
    Schilling S; Niestroj AJ; Rahfeld JU; Hoffmann T; Wermann M; Zunkel K; Wasternack C; Demuth HU
    J Biol Chem; 2003 Dec; 278(50):49773-9. PubMed ID: 14522962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development.
    Koch B; Buchholz M; Wermann M; Heiser U; Schilling S; Demuth HU
    Chem Biol Drug Des; 2012 Dec; 80(6):937-46. PubMed ID: 22967026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions.
    Schilling S; Hoffmann T; Manhart S; Hoffmann M; Demuth HU
    FEBS Lett; 2004 Apr; 563(1-3):191-6. PubMed ID: 15063747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid.
    Gontsarova A; Kaufmann E; Tumani H; Dressel A; Mandel F; Wiesmüller KH; Kunert-Keil C; Brinkmeier H
    Clin Chim Acta; 2008 Mar; 389(1-2):152-9. PubMed ID: 18187042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Snake venom glutaminyl cyclases: purification, cloning, kinetic study, recombinant expression, and comparison with the human enzyme.
    Wang YM; Huang KF; Tsai IH
    Toxicon; 2014 Aug; 86():40-50. PubMed ID: 24814012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding.
    Huang KF; Liaw SS; Huang WL; Chia CY; Lo YC; Chen YL; Wang AH
    J Biol Chem; 2011 Apr; 286(14):12439-49. PubMed ID: 21288892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides.
    Fischer WH; Spiess J
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3628-32. PubMed ID: 3473473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational evidence for the catalytic mechanism of glutaminyl cyclase. A DFT investigation.
    Calvaresi M; Garavelli M; Bottoni A
    Proteins; 2008 Nov; 73(3):527-38. PubMed ID: 18470930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-directed mutagenesis of the conserved Ala348 and Gly350 residues at the putative active site of Bacillus kaustophilus leucine aminopeptidase.
    Chi MC; Liu JS; Wang WC; Lin LL; Huang HB
    Biochimie; 2008 May; 90(5):811-9. PubMed ID: 18157952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate and inhibitor specificity of glutamine cyclotransferase (QC).
    Gololobov MY; Wang W; Bateman RC
    Biol Chem Hoppe Seyler; 1996 Jun; 377(6):395-8. PubMed ID: 8839986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of replacing active site residues in a cold-active alkaline phosphatase with those found in its mesophilic counterpart from Escherichia coli.
    Gudjónsdóttir K; Asgeirsson B
    FEBS J; 2008 Jan; 275(1):117-27. PubMed ID: 18067583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zn2+-linked dimerization of UreG from Helicobacter pylori, a chaperone involved in nickel trafficking and urease activation.
    Zambelli B; Turano P; Musiani F; Neyroz P; Ciurli S
    Proteins; 2009 Jan; 74(1):222-39. PubMed ID: 18767150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship.
    Buchholz M; Heiser U; Schilling S; Niestroj AJ; Zunkel K; Demuth HU
    J Med Chem; 2006 Jan; 49(2):664-77. PubMed ID: 16420052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution NMR structure of the iron-sulfur cluster assembly protein U (IscU) with zinc bound at the active site.
    Ramelot TA; Cort JR; Goldsmith-Fischman S; Kornhaber GJ; Xiao R; Shastry R; Acton TB; Honig B; Montelione GT; Kennedy MA
    J Mol Biol; 2004 Nov; 344(2):567-83. PubMed ID: 15522305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.